The effect of vitamin A supplementation on disease progression, Cytokine levels and gene expression in multiple sclerotic patients: Study protocol for a randomized controlled trial

Acta Medica Iranica

Volumn 52, Issue 2, 2014, Pages 94-100

  Harrirchian, Mohammad Hassan ^a   Honarvar, Niyaz Mohammadzadeh ^b   Koohdani, Fariba ^b   Bitarafan, Sama ^b   Siassi, Fereydoon ^b   Jafarirad, Sima ^b,c   Abdolahi, Mina ^b   Salehi, Eisa ^b   Saharian, Mohammad Ali ^d   Rouystaee, Homa ^b   Eshraghian, Mohammad Reza ^b   Saboor Yarghi, Ali Akbar ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokine; Gene expression; Magnetic resonance imaging; Multiple sclerosis; Vitamin A

Indexed keywords

BETA ACTIN; BETA1A INTERFERON; CHOLESTEROL; CINOVEX; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; MESSENGER RNA; PLACEBO; PREALBUMIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOL; RETINOL BINDING PROTEIN; RETINOL PALMITATE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATES SCALE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; LIVER FUNCTION TEST; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; VITAMIN SUPPLEMENTATION; YOUNG ADULT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

CYTOKINES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; GENE EXPRESSION REGULATION; HUMANS; MULTIPLE SCLEROSIS; PLACEBOS; REAL-TIME POLYMERASE CHAIN REACTION; VITAMIN A;

EID: 84900028884     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Chen SJ, Wang YL, Fan HC, et al. Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis. Clin Dev Immunol 2012;2012:970789.
2. Fox RJ, Beall E, Bhattacharyya P, et al. Advanced MRI in Multiple Sclerosis. Current Status and Future Challenges. Neurol Clin 2011;29(2):357-80.
3. Frohman EM, Racke MK, Raine CS. Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med 2006;354(9):942-55.
4. Comabella M, Khoury SJ. Immunopathogenesis of multiple sclerosis. Clin Immunol 2012;142(1):2-8.
5. Jadidi-Niaragh F, Mirshafiey A. Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis. Scand J Immunol 2011;74(1):1-13.
6. Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009;206(8):1653-60.
7. Serres S, Anthony DC, Jiang Y, et al. Systemic Inflammatory Response eactivates Immune-Mediated Lesions in Rat Brain. J Neurosci 2009;29(15):4820-8.
8. Boppana S, Huang H, Ito K, et al. Immunologic Aspects of Multiple Sclerosis. Mt Sinai J Med 2011;78(2):207-20.
9. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci 2004;223(1):13-24.
10. Prat A, Biernacki K, Lavoie JF, et al. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 2002;59(3):391-7.
11. Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008;181(4):2277-84.
12. Mucida D, Park Y, Kim G, et al, Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317(5835):256-60.
13. Lovett-Racke AE, Racke MK. Retinoic acid promotes the development of Th2-like human myelin basic proteinreactive T cells. Cell Immunol 2002;215(1):54-60.
14. Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses:New insightsinto coordinated regulation of the PPAR-RXR complex. FEBS Lett 2008;582(1):32-8.
15. Parés X, Farrés J, Kedishvili N, et al. Medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell Mol Life Sci 2008;65(24):3936-49.
16. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004;23(1):S208-19
17. Jenkinson M, Bannister P, Brady M, et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images. Neuro Image 2002;17(2):825-41.
18. Smith SM, Brady JM. SUSAN-A New Approach to Low Level Image Processing. Int J Comput Vis 1997;23(1):45-78.
19. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis. NeuroImage 2002;17(1):479-89.
20. Bach MK, Brashler JR. Isolation of subpopulations of lymphocytic cells by the use of isotonically balanced solutions of Ficoll. I. Development of methods and demonstration of the existence of a large but finite number of subpopulations. Exp Cell Res 1970;61(2):387-96.
21. Mottaghi A, Salehi E, Sezavar H, et al. The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients with Atherosclerosis. Iran J Allergy Asthma Immunol 2012;11(3):217-23.
22. Zago LB, Dupraz H, Sarchi MI, et al. The molar ratio of retinol-binding protein to transthyretin in the assessment of vitamin A status in adults. Proposal of a cut-off point. Clin Chem Lab Med 2002;40(12):1301-7.
23. Loma I, Heyman R. Multiple Sclerosis:Pathogenesis and Treatment. Curr Neuropharmacol 2011;9(3):409-16.
24. Jäger A, Dardalhon V, Sobel RA, et al. Th1, Th17 and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009;183(11):7169-77.
25. Pappas DJ, Oksenberg JR. Multiple sclerosis pharmacogenomics:maximizing efficacy of therapy. Neurology 2010;74(1):S62-9.
26. Hall JA, Cannons JL, Grainger JR, et al. Essential Role for Retinoic Acid in the Promotion of CD4(+) T Cell Effector Responses via Retinoic Acid Receptor Alpha. Immunity 2011;34(3):435-47.
27. Cassani B, Villablanca EJ, De Calisto J, et al. Vitamin A and immune regulation: Role of retinoic acid in gutassociated dendritic cell education, immune protection and tolerance. Mol Aspects Med 2012;33(1):63-76.
28. Jafarirad S, Siassi F, Harirchian MH, et al. The Effect of Vitamin A Supplementation on Stimulated T-cell Proliferation with Myelin Oligodendrocyte Glycoprotein in Patients with Multiple Sclerosis. J Neurosci Rural Pract 2012;3(3):294-8.
29. Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic Acid in the Immune System. Ann N Y Acad Sci 2008;1143(21):170-87.